What are the anti-kidney cancer drugs?

Kidney cancer, also known as renal cell carcinoma or renal adenocarcinoma, is the most common malignant tumor of the kidney. Due to the increase in average life expectancy and the advancement of medical imaging, the incidence of kidney cancer has increased. The number of kidney cancers that are accidentally discovered during physical examinations without obvious clinical symptoms is increasing, reaching 1/2 to 1/5. So what are the anti-kidney cancer drugs?

Kidney cancer, also known as renal cell carcinoma and renal adenocarcinoma, is the most common malignant tumor of the kidney. Western medicines used to treat kidney cancer include: sorafenib tosylate tablets, hydroxyurea tablets, tegafur tablets, medroxyprogesterone acetate dispersible tablets, etc. Traditional Chinese medicine generally chooses broad-spectrum anticancer drugs or anti-tumor drugs. Effective treatment of kidney cancer also requires combined use of drugs based on the patient's symptoms.
At present, chemotherapy drugs for renal cancer have made continuous progress, and patients have greatly improved in both tolerance and adaptability. Combining cellular immunotherapy after chemotherapy can increase the activity of the patient's own immune cells, improve the body's autonomous anti-cancer immune ability, enhance the effect of chemotherapy, and reduce the toxic and side effects of chemotherapy.
In addition, among the treatment methods for kidney cancer, surgical treatment of kidney cancer is usually the first choice of treatment and is currently recognized as a means of curing kidney cancer. For patients with early kidney cancer, nephron-sparing surgery (surgery to preserve the kidney) or radical nephrectomy can be used. These operations can be performed using laparoscopic surgery or traditional open surgery. Radical nephrectomy is usually used for patients with intermediate and stage kidney cancer, and this type of surgery is usually performed using open surgery.